IRCT20130701013828N8招募中3 期
Protective effects of Bisoprolol against anthracycline-induced cardiomyopathyin in breast cancer patient
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 years 至 75 years（—）
- 性别
- Female
入选标准
- •Patients with breast cancer
- •Patients with indication for AC (doxorubicin hydrochloride (Adriamycin) and cyclophosphamide) regimen for chemotherapy
- •Patients agreement
排除标准
- •Patients non compliance
- •Patients who have cardiovascular problems
- •Have previously undergone chest radiotherapy
- •Patients who have allergy to Bisoprolol
- •Patients currently taking beta-blockers
- •Patients who have contraindicated for use beta blockers.
研究者
相似试验
已完成
3 期
Bisoprolol Administration to Prevent Anthracycline-induced CardiotoxicityCardiomyopathiesChemotherapy EffectDiastolic DysfunctionSystolic DysfunctionNCT05175066Shahid Beheshti University of Medical Sciences80
已完成
不适用
Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseJPRN-UMIN000024712Okayama University35
尚未招募
4 期
Evaluation of the preventive effect of bisoprolol fumarate on postoperative hypertension and atrial fibrillation in in eldery patient on acute and chronic phase.Postoperative atrial fibrillationJPRN-UMIN000004600Tohoku University Hospital Cardiovascular Surgery100
已完成
2 期
Evaluation of preventive effect of bisoprolol in sub clinical Heart failureIRCT20240609062050N1Iran University of Medical Sciences70
尚未招募
不适用
The protective role of the administration of antibiotics on the occurrence of sepsis after removal of ventral venous catheters in neonates.10004018sepsisNL-OMON31570niversitair Medisch Centrum Utrecht266